Shares of ACADIA Pharmaceuticals Inc. (ACAD) were up 24% in after-hours on Tuesday, following positive vote from an FDA panel for the company’s NUPLAZID for the treatment of psychosis associated with Parkinson’s disease.
Forex – financial instrument.Forex news
Shares of ACADIA Pharmaceuticals Inc. (ACAD) were up 24% in after-hours on Tuesday, following positive vote from an FDA panel for the company’s NUPLAZID for the treatment of psychosis associated with Parkinson’s disease.